Morgan Stanley’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $760K | Sell |
|
|||||
|
2025
Q1 | $438K | Buy |
|
|||||
|
2024
Q4 | $332K | Sell |
|
|||||
|
2024
Q3 | $768K | Buy |
|
|||||
|
2024
Q2 | $525K | Buy |
|
|||||
|
2024
Q1 | $679K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | $328K | Buy |
|
|||||
|
2023
Q2 | $215K | Sell |
|
|||||
|
2023
Q1 | $459K | Buy |
|
|||||
|
2022
Q4 | $154K | Buy |
|
|||||
|
2022
Q3 | $70K | Sell |
|
|||||
|
2022
Q2 | $203K | Sell |
|
|||||
|
2022
Q1 | $376K | Sell |
|
|||||
|
2021
Q4 | $1.29M | Buy |
|
|||||
|
2021
Q3 | $316K | Sell |
|
|||||
|
2021
Q2 | $367K | Buy |
|
|||||
|
2021
Q1 | $259K | Sell |
|
|||||
|
2020
Q4 | $228K | Buy |
|
|||||
|
2020
Q3 | $50K | Sell |
|
|||||
|
2020
Q2 | $73K | Buy |
|
|||||
|
2020
Q1 | $48K | Sell |
|
|||||
|
2019
Q4 | $175K | Buy |
|
|||||
|
2019
Q3 | $76K | Buy |
|
|||||
|
2019
Q2 | $51K | Sell |
|
|||||
|
2019
Q1 | $85K | Sell |
|
|||||
|
2018
Q4 | $166K | Sell |
|
|||||
|
2018
Q3 | $469K | Sell |
|
|||||
|
2018
Q2 | $499K | Buy |
|
|||||
|
2018
Q1 | $648K | Sell |
|
|||||
|
2017
Q4 | $552K | Buy |
|
|||||
|
2017
Q3 | $461K | Buy |
|
|||||
|
2017
Q2 | $315K | Sell |
|
|||||
|
2017
Q1 | $509K | Sell |
|
|||||
|
2016
Q4 | $754K | Buy |
|
|||||
|
2016
Q3 | $80K | Buy |
|
|||||
|
2016
Q2 | $28K | Buy |
|
|||||
|
2016
Q1 | $12K | Sell |
|
|||||
|
2015
Q4 | $92K | Buy |
|
|||||
|
2015
Q3 | $43K | Sell |
|
|||||
|
2015
Q2 | $313K | Buy |
|
|||||
|
2015
Q1 | $185K | Sell |
|
|||||
|
2014
Q4 | $384K | Sell |
|
|||||
|
2014
Q3 | $570K | Sell |
|
|||||
|
2014
Q2 | $770K | Sell |
|
|||||
|
2014
Q1 | $845K | Buy |
|
|||||
|
2013
Q4 | $355K | Buy |
|
|||||
|
2013
Q3 | $116K | Buy |
|
|||||
|
2013
Q2 | $57K | Buy |
|